Mabgeek Biotech and Medium Bank have reached a deep strategic cooperation.

On October 25, 2022, Shanghai Mabgeek Biotech Co., Ltd. (Mabgeek, hereinafter referred to as " Mabgeek ") and Shanghai Medium Bank Co., Ltd. (MEDIUM BANK, hereinafter referred to as "Medium Bank Bio") reached a deep strategic cooperation on the optimization development and long-term stable supply of platform culture medium. This strategic cooperation will give full play to Maibang Bio's technical and resource advantages in culture medium products, culture medium optimization and development services, and further promote the industrialization process of Maibang Bio's innovative antibody drug projects.

Dr. Zhang Chenghai, co-founder and CEO of Mabgeek Biotech, and Wang Yantao, founder and CEO of Medium Bank

Group photo of participants

Dr. Zhang Chenghai, founder of Mabgeek Biotech, said: " Mabgeek Biotech is committed to the independent research and development and commercialization of innovative antibody drugs. It has very strong innovative research and development capabilities in the fields of allergic inflammatory diseases and autoimmune diseases. Many projects have entered the clinical research stage, and some projects are about to enter the commercial production stage. Medium Bank  has participated in the project promotion process since the early stage of the project. Through high-performance culture medium products and its team's deep understanding of the process, we have greatly increased the output of drugs while ensuring that key quality parameters meet the standards. I am very happy to reach a strategic cooperation with Medium Bank to jointly revitalize the national industry. ”

Dr. Zhang Chenghai, co-founder and CEO of Mabgeek Biotech

 Wang Yantao, founder and CEO of Medium Bank, said: "It is a great honor to become a strategic partner with Mabgeek Biotech, and we are very grateful for this trust! With the continuous development and upgrading of Medium Bank in product research and development, capacity construction, quality management system, etc., we have the ability to provide stable supply for domestic biopharmaceutical companies. As a domestic high-end CD culture medium product and a service provider of upstream comprehensive solutions such as culture medium optimization and development for biopharmaceutical companies, we will continue to adhere to the deep cultivation in this field, adhering to the purpose of professionalism, focus and win-win, and give full play to our product, technology and service advantages. We believe that Maibang Bio will become your trustworthy partner, empowering each other and working together for a win-win situation. ”

Wang Yantao, founder and CEO of Maibang Bio